Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Cash from Investing Activities over the past 9 years, most recently at $10.4 million for Q4 2023.

  • For Q4 2023, Cash from Investing Activities fell 11.81% year-over-year to $10.4 million; the TTM value through Dec 2023 reached $35.6 million, up 18.51%, while the annual FY2024 figure was -$121.3 million, 440.36% down from the prior year.
  • Cash from Investing Activities for Q4 2023 was $10.4 million at Corbus Pharmaceuticals Holdings, down from $10.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $43.0 million in Q1 2022 and troughed at -$57.4 million in Q1 2021.
  • A 5-year average of -$546371.2 and a median of -$65206.5 in 2019 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 600.2% in 2021 and fell as far as 80886.76% in 2021.
  • Year by year, Cash from Investing Activities stood at -$1.3 million in 2019, then skyrocketed by 104.03% to $52086.0 in 2020, then crashed by 6200.27% to -$3.2 million in 2021, then surged by 470.74% to $11.8 million in 2022, then dropped by 11.81% to $10.4 million in 2023.
  • Business Quant data shows Cash from Investing Activities for CRBP at $10.4 million in Q4 2023, $10.9 million in Q3 2023, and $8.8 million in Q2 2023.